We use cookies for a better user experience. Read our Privacy Policy

I Agree

Europe Molecular Diagnostics Market

Molecular Diagnostics Market (Product - Real-time PCR Systems, Liquid Handling Systems, and DNA Extraction Systems; End User - Hospitals, Diagnostic Laboratories, Academic and Research Institutes, and Pharmaceutical and Biotechnology Companies) - Europe Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 - 2025

Innovation in molecular diagnostic techniques has resulted in detection of numerous diseases. It is more effective in case of challenging differential diagnosis. Further, technological advancement in molecular diagnostics are likely to drive the market growth substantially. The growth rate is attributed to portability, accuracy, cost-effectiveness of the diagnostic method.

Nanopore has commercialized use of MinION, which is an affordable and portable sequencer. It is suitable for application in small laboratories and point-of-care medical facilities. Wide adoption rate of MinION is likely to boost growth of molecular diagnostics market.

As per a report published by the World Health Organization (WHO), the average rate of hospital acquired infections in 2019 varied in between 4.5 and 7.1% in U.S. and Europe, respectively. Molecular diagnosis technique tends to provide quick and effective results. Thus, hospital acquired infections and infectious diseases are anticipated to drive the demand for molecular diagnostics market in coming years.

Further, growing investment by government bodies and other organizations for R&D activities in molecular diagnostics is likely to fuel the market. Funding plays an important role in the product development process. For example, Accelerate Diagnostics received USD 19.5 million from various organizations such as the Schuler Family Foundation, Oracle Partners, and Oracle Institutional Partners. The funds aided to increase development and sales of diagnostics tests and tools.

Regulations for approvals have always posed several restrictions on biotechnology, pharmaceuticals, and medical technology industries. Use of faulty diagnostics could provide incorrect results, which may be proved as fatal in future. To avoid such circumstance, FDA has framed strict approval regulations to ensure compliance of the diagnostic equipment with medical standards.  In case of molecular diagnostics, FDA has become conscious, owing to dependency on molecular diagnostics for making critical decisions. 

Europe Molecular Diagnostics Market: Snapshot

The demand for molecular diagnostic systems has been increasing owing to the increasing automation in the research process. These systems aid in automating the process of DNA extraction, amplification and recording the analysis data. In addition, these systems offer a range of advantages such as increased efficiency, correctness of the data, and decrease in the time required, which contribute to garner market growth. Against this background, the Europe molecular diagnostics market is expected to be worth US$769.0 mn by the end of 2025 from US$395.7 mn in 2016. During the forecast period of 2017 and 2025, the regional market is expected to register a CAGR of 6.6%.

On the basis product, the market has been segmented into real-time PCR systems, liquid handling systems, and DNA extraction systems. The market for real-time PCR systems is anticipated to remain strong in the forecast period, both in terms of value and volume. These systems are anticipated to record the strong growth owing to the range of advantages offered by these systems in comparison to the conventional PCR systems. Some of the benefits are analysis of amplified DNA in the exponential stage which provides a better study, decreases the fear of sample contamination as the process of amplification to analysis is done in the same tube along with increase in throughput among others. Furthermore, the market has witnessed an increase in the installed base of these systems, which can be attributed to their declining prices. This segment is anticipated to be trailed by liquid handling systems, whose growth can be attributed to the increasing demand for laboratory automation for effective and correctness in the liquid dispensing process.europe molecular diagnostics market

Pharmaceutical and Biotechnology Companies to be Key Users of Molecular Diagnostics

In terms of end user, the Europe molecular diagnostics market has been segmented into hospitals, diagnostic laboratories, academic and research institutes, and pharmaceutical and biotechnology companies. Pharmaceutical and biotechnology companies are anticipated to be the fastest growing segment, owing to their increasing investments on research that contributes to the growth in adoption of molecular diagnostic devices. This segment is closely trailed by academic and research institutes. The growth in this segment can be attributed to the increasing public and private funding for research. For instance, Europa Organization, the European funding organization, supports innovative companies in the development of new products and conducts annual PCR conferences to identify potential innovators of PCR technology.

Germany to Retain Dominance in Europe Molecular Diagnostics Market

Geographically, Europe region is segmented into five main countries, including the U.K., France, Germany, Italy and Spain; and Rest of Europe. Germany was the leading country in terms of revenues in 2016. It is anticipated to maintain its dominance and grow a significantly high CAGR during the forecast period. The strong growth of molecular diagnostics in Germany can be attributed to the government focus on healthcare investments, increased focus on enhancing the biotechnology sector, and the increasing number of biotechnology companies in the country.

Some of the leading players in the Europe molecular diagnostics market report are Agilent Technologies, Inc., Dickinson and Company, Becton, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Eppendorf AG, PerkinElmer, Inc., Tecan Group Ltd., Thermo Fisher Scientific, Inc., and QIAGEN N.V., among others.

The Molecular Diagnostics Market has been segmented as follows:?

by Product

  • Real Time- PCR Systems
    • LightCycler 480
    • PCRmax Eco 48
    • Applied Biosystems 7900HT
    • QuantStudio Real-Time PCR
    • ViiA 7 Real-Time PCR
    • C1000 Touch
    • ABI StepOnePlus Real-Time PCR
    • 5ABI 7500
    • AriaMx Real-time PCR System
    • CFX Connect
    • CFX384 Touch
    • MiniOpticon
    • Others
  • Liquid Handling System
    • epMotion
    • Biomek
    • Freedom EVO
    • Tecan D300e Digital Dispenser
    • Precision
    • JANUS
    • Others
  • DNA Extraction System
    • AutoMate Express
    • QIAcube
    • InnuPure
    • VERSA
    • chemagic
    • Others

by End-User

  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies

by Country

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe
Europe Molecular Diagnostics Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

1. Preface
      1.1. Market Definition and Scope
      1.2. Market Segmentation
      1.3. Key Research Objectives
      1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Europe Molecular Diagnostics Market

4. Market Overview
      4.1. Introduction
      4.2. Key Market Indicators
      4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunity
      4.4. Europe Molecular Diagnostics Market Analysis and Forecasts, 2015–2025
            4.4.1. Market Revenue (US$ Mn) and Volume (units) Projections
            4.4.2. Installed Base- Global (units) 
      4.5. Porter’s Five Force Analysis
      4.6. Value Chain Analysis
      4.8. Regulatory approval process
      4.9. Market Outlook

5. Europe Molecular Diagnostics Market Analysis and Forecasts, By Product 
      5.1. Introduction & Definition 
      5.2. Key Findings / Developments 
      5.3. Key Trends 
      5.4. Market Size (US$ Mn) and Volume (Units) Forecast, By Product
            5.4.1. Real Time- PCR Systems 
                     5.4.1.1. LightCycler 480 
                     5.4.1.2. PCRmax Eco 48 
                     5.4.1.3. Applied Biosystems 7900HT 
                     5.4.1.4. QuantStudio Real-Time PCR 
                     5.4.1.5. ViiA 7 Real-Time PCR 
                     5.4.1.6. C1000 Touch 
                     5.4.1.7. ABI StepOnePlus Real-Time PCR 
                     5.4.1.8. ABI 7500 
                     5.4.1.9. AriaMx Real-time PCR System 
                     5.4.1.10. CFX Connect 
                     5.4.1.11. CFX384 Touch 
                     5.4.1.12. MiniOpticon 
                     5.4.1.13. Others 
            5.4.2. Liquid Handling System 
                     5.4.2.1. epMotion 
                     5.4.2.2. Biomek 
                     5.4.2.3. Freedom EVO 
                     5.4.2.4. Tecan D300e Digital Dispenser 
                     5.4.2.5. Precision 
                     5.4.2.6. JANUS 
                     5.4.2.7. Others
            5.4.3. DNA Extraction System 
                     5.4.3.1. AutoMate Express 
                     5.4.3.2. QIAcube 
                     5.4.3.3. InnuPure 
                     5.4.3.4. VERSA 
                     5.4.3.5. chemagic 
                     5.4.3.6. Others
      5.5. Market Attractiveness, By Product

6. Europe Molecular Diagnostics Market Analysis and Forecasts, By End-user 
      6.1. Introduction & Definition 
      6.2. Key Findings / Developments 
      6.3. Key Trends
      6.4. Market Size (US$ Mn) and volume (units) Forecast, By End-user 
            6.4.1. Hospital 
            6.4.2. Diagnostics Laboratories 
            6.4.3. Academics & Research Institutes 
            6.4.4. Pharmaceutical & Biotechnology Companies 
      6.5. Market Attractiveness By End-user

7. Molecular Diagnostics Market Analysis and Forecasts, By Country 
      7.1. Introduction & Definition 
      7.2. Key Findings / Developments 
      7.3. Market Size (US$ Mn) Forecast, By Country 
            7.3.1. U.K. 
            7.3.2. France 
            7.3.3. Germany 
            7.3.4. Italy 
            7.3.5. Spain 
            7.3.6. Rest of Europe 
      7.4. Market Attractiveness By Country

8. Competition Landscape
      8.1. Market Player – Competition Matrix (By Tier and Size of companies)
      8.2. Market Share Analysis By Company (2016)
      8.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            8.3.1. Agilent Technologies, Inc.
                     8.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                     8.3.1.2. Business Overview
                     8.3.1.3. Product Portfolio 
                     8.3.1.4. Financial Overview 
                     8.3.1.5. SWOT Analysis 
                     8.3.1.6. Strategic overview
            8.3.2. Becton, Dickinson and Company
                     8.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                     8.3.2.2. Business Overview
                     8.3.2.3. Product Portfolio 
                     8.3.2.4. Financial Overview 
                     8.3.2.5. SWOT Analysis 
                     8.3.2.6. Strategic overview
            8.3.3. Bio-Rad Laboratories, Inc.
                     8.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                     8.3.3.2. Business Overview
                     8.3.3.3. Product Portfolio 
                     8.3.3.4. Financial Overview 
                     8.3.3.5. SWOT Analysis 
                     8.3.3.6. Strategic overview
            8.3.4. Danaher Corporation
                     8.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                     8.3.4.2. Business Overview
                     8.3.4.3. Product Portfolio 
                     8.3.4.4. Financial Overview 
                     8.3.4.5. SWOT Analysis 
                     8.3.4.6. Strategic overview
            8.3.5. Eppendorf AG
                     8.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                     8.3.5.2. Business Overview
                     8.3.5.3. Product Portfolio 
                     8.3.5.4. Financial Overview 
                     8.3.5.5. SWOT Analysis 
                     8.3.5.6. Strategic overview
            8.3.6. F. Hoffmann-La Roche Ltd.
                     8.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                     8.3.6.2. Business Overview
                     8.3.6.3. Product Portfolio 
                     8.3.6.4. Financial Overview 
                     8.3.6.5. SWOT Analysis 
                     8.3.6.6. Strategic overview
            8.3.7. PerkinElmer, Inc.
                     8.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                     8.3.7.2. Business Overview
                     8.3.7.3. Product Portfolio 
                     8.3.7.4. Financial Overview 
                     8.3.7.5. SWOT Analysis 
                     8.3.7.6. Strategic overview
            8.3.8. QIAGEN N.V.
                     8.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                     8.3.8.2. Business Overview
                     8.3.8.3. Product Portfolio 
                     8.3.8.4. Financial Overview 
                     8.3.8.5. SWOT Analysis 
                     8.3.8.6. Strategic overview
            8.3.9. Tecan Group Ltd.
                     8.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                     8.3.9.2. Business Overview
                     8.3.9.3. Product Portfolio 
                     8.3.9.4. Financial Overview 
                     8.3.9.5. SWOT Analysis 
                     8.3.9.6. Strategic overview
            8.3.10. Thermo Fisher Scientific, Inc.
                     8.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                     8.3.10.2. Business Overview
                     8.3.10.3. Product Portfolio 
                     8.3.10.4. Financial Overview 
                     8.3.10.5. SWOT Analysis 
                     8.3.10.6. Strategic overview

List of Tables

Table 01: Europe Molecular Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, by Product, 2017–2025
Table 02: Europe Molecular Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, by Product – Real-time PCR Systems, 2017–2025
Table 03: Europe Molecular Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, by Product – Liquid Handling Systems, 2017–2025
Table 04: Europe Molecular Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, by Product – DNA Extraction Systems, 2017–2025
Table 05: Europe Molecular Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, by End-user, 2015–2025
Table 06: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017–2025    

List of Figures

Figure 01: Europe Molecular Diagnostics Market Size (US$ Mn) and Volume (units), and Forecast, 2017–2025
Figure 02: Market Value Share By Product (2017)
Figure 03: Market Value Share By End-user (2017)
Figure 04: Market Value Share By Country (2017)
Figure 05: Europe Molecular Diagnostics Market Value Share Analysis, by Product, 2016 and 2025
Figure 06: Europe Real-time PCR Systems Market Revenue (US$ Mn) and Volume (Units), 2015–2025
Figure 07: Europe Liquid Handling Systems Market Revenue (US$ Mn) and Volume (Units), 2015–2025
Figure 08: Europe DNA Extraction Systems Market Revenue (US$ Mn) and Volume (Units), 2015–2025
Figure 09: Europe Molecular Diagnostics Market Attractiveness Analysis, by Product
Figure 10: Europe Molecular Diagnostics Market Value Share Analysis, by End-user, 2016 and 2025
Figure 11: Europe Hospitals Market Revenue (US$ Mn) and Volume (Units) 2015–2025
Figure 12: Europe Diagnostic Laboratories Market Revenue (US$ Mn) and Volume (Units), 2015–2025
Figure 13: Europe Academic and Research Institutes Market Revenue (US$ Mn) and Volume (Units), 2015–2025
Figure 14: Europe Pharmaceutical and Biotechnology Companies Market Revenue (US$ Mn) and Volume (Units), 2015–2025
Figure 15: Molecular Diagnostics Market Attractiveness Analysis, by End-user
Figure 16: Europe Molecular Diagnostics Market Value Share Analysis, by Country, 2016 and 2025
Figure 17: Europe Molecular Diagnostics Market Attractiveness Analysis, by Country
Figure 18: Europe Molecular Diagnostics Market Share Analysis, by Company (2016)

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

898

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved